• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Pharmacovigilance and spontaneous adverse drug reaction reporting: Challenges and opportunities.药物警戒与自发药品不良反应报告：挑战与机遇
Perspect Clin Res. 2022 Oct-Dec;13(4):177-179. doi: 10.4103/picr.picr_169_22. Epub 2022 Sep 27.
2
Postmarketing Safety of Biosimilars: Current Status, Challenges, and Opportunities in the Spontaneous Reporting System.生物类似药的上市后安全性：自发报告系统的现状、挑战和机遇。
Ther Innov Regul Sci. 2020 May;54(3):667-680. doi: 10.1007/s43441-019-00101-6. Epub 2020 Jan 6.
3
Post marketing surveillance of suspected adverse drug reactions through spontaneous reporting: current status, challenges and the future.通过自发报告对疑似药品不良反应进行上市后监测：现状、挑战与未来。
Ther Adv Drug Saf. 2020 Aug 10;11:2042098620938595. doi: 10.1177/2042098620938595. eCollection 2020.
4
Postmarketing Safety of Biosimilars: Current Status, Challenges, and Opportunities in the Spontaneous Reporting System.生物类似药的上市后安全性：自发报告系统的现状、挑战与机遇
Ther Innov Regul Sci. 2019 Sep 26:2168479019872144. doi: 10.1177/2168479019872144.
5
Patients' Perspectives on Adverse Drug Reaction Reporting in a Developing Country: A Case Study from Ghana.发展中国家患者对药品不良反应报告的看法：来自加纳的案例研究
Drug Saf. 2017 Oct;40(10):911-921. doi: 10.1007/s40264-017-0563-9.
6
Safety of medicines-Pharmacists' knowledge, practice, and attitudes toward pharmacovigilance and adverse drug reactions reporting process.药品安全 - 药剂师对药物警戒和药物不良反应报告流程的知识、实践和态度。
Pharmacoepidemiol Drug Saf. 2019 Dec;28(12):1543-1551. doi: 10.1002/pds.4792. Epub 2019 May 30.
7
Considerations on the use of different comparators in pharmacovigilance: A methodological review.药物警戒中不同对照的使用考量：方法学综述。
Br J Clin Pharmacol. 2023 Sep;89(9):2671-2676. doi: 10.1111/bcp.15802. Epub 2023 Jun 8.
8
Targeted Spontaneous Reporting: Assessing Opportunities to Conduct Routine Pharmacovigilance for Antiretroviral Treatment on an International Scale.针对性自发报告：评估在国际范围内开展抗逆转录病毒治疗常规药物警戒的机会。
Drug Saf. 2016 Oct;39(10):959-76. doi: 10.1007/s40264-016-0434-9.
9
Optimizing spontaneous adverse drug reaction reporting in public healthcare setting in Namibia.优化纳米比亚公共医疗环境中的自发药物不良反应报告。
Basic Clin Pharmacol Toxicol. 2020 Mar;126(3):247-253. doi: 10.1111/bcpt.13325. Epub 2019 Oct 23.
10
Impact of Covid-19 Vaccination on Spontaneous Pharmacovigilance Reporting in France.Covid-19 疫苗接种对法国自发药物警戒报告的影响。
Drug Saf. 2023 Dec;46(12):1381-1389. doi: 10.1007/s40264-023-01359-4. Epub 2023 Nov 5.

引用本文的文献

1
Trends in cannabis adverse reaction reports: A descriptive analysis of spontaneous reporting data submitted to the Canada Vigilance Program since legalization and regulation of cannabis for non-medical purposes in Canada.大麻不良反应报告趋势：对加拿大非医疗用途大麻合法化和监管以来提交给加拿大警戒计划的自发报告数据的描述性分析。
J Cannabis Res. 2025 Aug 12;7(1):56. doi: 10.1186/s42238-025-00310-x.
2
Assessment of pharmacovigilance knowledge and ADR reporting skills in undergraduate medical students using the OSPA model.使用OSPA模型评估本科医学生的药物警戒知识和药品不良反应报告技能。
Dialogues Health. 2025 Jul 3;7:100227. doi: 10.1016/j.dialog.2025.100227. eCollection 2025 Dec.
3
The Knowledge, Attitudes, and Experiences of Traditional Korean Medicine Doctors in the Spontaneous Reporting of Adverse Drug Events: A Cross-Sectional Survey.韩国传统医学医生在药品不良反应自发报告方面的知识、态度和经历：一项横断面调查。
Healthcare (Basel). 2025 Jul 7;13(13):1620. doi: 10.3390/healthcare13131620.
4
Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study.GLP1受体激动剂及其他糖尿病药物引发自杀、脱发和误吸的风险：一项真实世界药物警戒研究
Cardiovasc Drugs Ther. 2024 Sep 12. doi: 10.1007/s10557-024-07613-w.
5
Barriers in reporting adverse effects of medical devices: a literature review.医疗器械不良反应报告中的障碍：一项文献综述。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb;398(2):1145-1153. doi: 10.1007/s00210-024-03431-x. Epub 2024 Sep 11.
6
Artificial intelligence in pharmacovigilance - Opportunities and challenges.药物警戒中的人工智能——机遇与挑战。
Perspect Clin Res. 2024 Jul-Sep;15(3):116-121. doi: 10.4103/picr.picr_290_23. Epub 2024 Mar 27.
7
Pharmacovigilance in Vaccines: Importance, Main Aspects, Perspectives, and Challenges-A Narrative Review.疫苗的药物警戒：重要性、主要方面、前景与挑战——一篇叙述性综述
Pharmaceuticals (Basel). 2024 Jun 19;17(6):807. doi: 10.3390/ph17060807.
8
Effectiveness and safety of regimen containing bedaquiline and delamanid in patients with drug-resistant tuberculosis.含贝达喹啉和地拉曼尼方案治疗耐多药结核病患者的有效性和安全性
Perspect Clin Res. 2024 Apr-Jun;15(2):89-93. doi: 10.4103/picr.picr_1_23. Epub 2023 Sep 11.

本文引用的文献

1
Impact of educational intervention on the knowledge, attitude, and practice of pharmacovigilance among postgraduates of a tertiary care center, Kanchipuram, Tamil Nadu, India.教育干预对印度泰米尔纳德邦坎奇普尔姆市一家三级护理中心研究生药物警戒知识、态度和实践的影响。
Perspect Clin Res. 2022 Oct-Dec;13(4):199-204. doi: 10.4103/picr.PICR_239_20. Epub 2021 May 15.
2
Increasing adverse drug reaction reporting-How can we do better?提高药物不良反应报告率——我们怎么做才能做得更好？
PLoS One. 2020 Aug 13;15(8):e0235591. doi: 10.1371/journal.pone.0235591. eCollection 2020.
3
An analysis of serious adverse drug reactions at a tertiary care teaching hospital.一家三级护理教学医院严重药物不良反应的分析。
Perspect Clin Res. 2016 Oct-Dec;7(4):181-186. doi: 10.4103/2229-3485.192044.
4
Social media and pharmacovigilance: A review of the opportunities and challenges.社交媒体与药物警戒：机遇与挑战综述
Br J Clin Pharmacol. 2015 Oct;80(4):910-20. doi: 10.1111/bcp.12717. Epub 2015 Sep 2.
5
WHO strategy for collecting safety data in public health programmes: complementing spontaneous reporting systems.世卫组织在公共卫生规划中收集安全数据的战略：补充自发报告系统。
Drug Saf. 2013 Feb;36(2):75-81. doi: 10.1007/s40264-012-0014-6.

Pharmacovigilance and spontaneous adverse drug reaction reporting: Challenges and opportunities.

作者信息

Desai Mira

机构信息

Department of Pharmacology, Nootan Medical College and Research Centre, Visnagar, Gujarat, India.

出版信息

Perspect Clin Res. 2022 Oct-Dec;13(4):177-179. doi: 10.4103/picr.picr_169_22. Epub 2022 Sep 27.

DOI:10.4103/picr.picr_169_22
PMID:36337368
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9635349/
Abstract
摘要